Premium
Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double‐blind, placebo‐controlled parallel‐group trial
Author(s) -
Talley N.J.,
Walker M.M.,
Jones M.,
Keely S.,
Koloski N.,
Cameron R.,
Fairlie T.,
Burns G.,
Shah A.,
Hansen T.,
Harris G.,
Holtmann G.
Publication year - 2021
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16396
Subject(s) - medicine , budesonide , eosinophilia , placebo , double blind , gastroenterology , randomized controlled trial , corticosteroid , pathology , alternative medicine